Abstract CT145: A phase I window, dose escalating and safety trial of Metformin in combination with induction chemotherapy (VPLD)in relapsed/refractory acute lymphoblastic leukemia: NCT01324180

Matteo Trucco; Julio Barredo; John Goldberg; Gregory Hale; Jonathan Gill; Bhuvana Setty; Tiffany Smith; Jae Lee; Damon Reed

doi:10.1158/1538-7445.AM2017-CT145

$Abstract CT145: A phase I window, dose escalating and safety trial of Metformin in combination with induction chemotherapy (VPLD)in relapsed/refractory acute lymphoblastic leukemia: NCT01324180$

Journal article

Peer reviewed

Abstract CT145: A phase I window, dose escalating and safety trial of Metformin in combination with induction chemotherapy (VPLD)in relapsed/refractory acute lymphoblastic leukemia: NCT01324180

Matteo Trucco, Julio Barredo, John Goldberg, Gregory Hale, Jonathan Gill, Bhuvana Setty, Tiffany Smith, Jae Lee and Damon Reed

Cancer research (Chicago, Ill.), Vol.77(13 Supplement), pp.CT145-CT145

2017-07-01

DOI: https://doi.org/10.1158/1538-7445.AM2017-CT145

Metrics

6 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Abstract CT145: A phase I window, dose escalating and safety trial of Metformin in combination with induction chemotherapy (VPLD)in relapsed/refractory acute lymphoblastic leukemia: NCT01324180
Creators: Matteo Trucco
Julio Barredo
John Goldberg
Gregory Hale
Jonathan Gill
Bhuvana Setty
Tiffany Smith
Jae Lee
Damon Reed
Publication Details: Cancer research (Chicago, Ill.), Vol.77(13 Supplement), pp.CT145-CT145
Academic Unit: Miller School of Medicine; UMMG Department of Pediatrics; UMMG Dept of Pediatrics - Hematology/Oncology/Stem Cell Transp
Language: English
Resource Type: Journal article
Record Identifier: 991031598279302976